Suppr超能文献

既往使用抗生素与社区获得性耐抗生素尿路感染风险:一项病例对照研究。

Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study.

作者信息

Hillier Sharon, Roberts Zoe, Dunstan Frank, Butler Chris, Howard Anthony, Palmer Stephen

机构信息

Department of Epidemiology, Centre for Health Sciences Research, Cardiff University, Neuadd Meirionydd, Heath Park, Cardiff CF14 4YS, UK.

出版信息

J Antimicrob Chemother. 2007 Jul;60(1):92-9. doi: 10.1093/jac/dkm141. Epub 2007 May 30.

Abstract

BACKGROUND

To assess the effect of previous antibiotic use on the risk of a resistant Escherichia coli urinary tract infection (UTI), we undertook a case-control study with prospective measurement of outcomes in 10 general practices in the UK.

METHODS

Urinary samples from all patients with symptoms suggestive of UTIs were sought, and those with a laboratory-proven E. coli infection were interviewed and their medical records examined. Case patients were those with ampicillin- or trimethoprim-resistant infections and control patients had infections that were susceptible to antibiotics, including ampicillin and trimethoprim.

RESULTS

Risk of ampicillin-resistant E. coli infection in 903 patients was associated with amoxicillin prescriptions of >or=7 days duration in the previous 1 month [odds ratio (OR)=3.91, 95% CI 1.64-9.34] and previous 2-3 months (2.29, 1.12-4.70) before illness onset. For prescriptions <7 days duration, there was no statistically significant association. Higher doses of amoxicillin were associated with lower risk of ampicillin resistance. For trimethoprim-resistant E. coli infections, the OR was 8.44 (3.12-22.86) for prescriptions of trimethoprim of >or=7 days in the previous month and 13.91 (3.32-58.31) for the previous 2-3 months. For trimethoprim prescriptions of <7 days, the OR was 4.03 (1.69-9.59) for the previous month but prescribing in earlier periods was not significantly associated with resistance.

CONCLUSIONS

Within the community setting, exposure to antibiotics is a strong risk factor for a resistant E. coli UTI. High-dose, shorter-duration antibiotic regimens may reduce the pressure on the emergence of antibiotic resistance.

摘要

背景

为评估既往使用抗生素对耐甲氧西林大肠杆菌尿路感染(UTI)风险的影响,我们在英国的10家普通诊所开展了一项病例对照研究,并对结局进行前瞻性测量。

方法

收集所有有UTI症状患者的尿液样本,对那些经实验室证实为大肠杆菌感染的患者进行访谈并检查其病历。病例患者为感染对氨苄西林或甲氧苄啶耐药的患者,对照患者的感染对包括氨苄西林和甲氧苄啶在内的抗生素敏感。

结果

903例患者中,氨苄西林耐药大肠杆菌感染的风险与发病前1个月内阿莫西林处方持续时间≥7天相关[比值比(OR)=3.91,95%置信区间1.64 - 9.34],以及发病前2 - 3个月(2.29,1.12 - 4.70)。对于处方持续时间<7天的情况,无统计学显著关联。较高剂量的阿莫西林与较低的氨苄西林耐药风险相关。对于甲氧苄啶耐药大肠杆菌感染,上个月甲氧苄啶处方持续时间≥7天的OR为8.44(3.12 - 22.86),前2 - 3个月为13.91(3.32 - 58.31)。对于上个月甲氧苄啶处方持续时间<7天的情况,OR为4.03(1.69 - 9.59),但早期处方与耐药无显著关联。

结论

在社区环境中,接触抗生素是耐甲氧西林大肠杆菌UTI的一个重要危险因素。高剂量、短疗程的抗生素治疗方案可能会降低抗生素耐药性出现的压力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验